BRIEF-Ipsen announces Health Canada approval of dysport therapeutic for treatment of patients with cervical dystonia
March 14, 2017 at 08:24 AM EDT
* Ipsen announces health canada approval of dysport therapeutic™ (abobotulinumtoxina) for the treatment of patients with cervical dystonia and adult upper limb spasticity Source text for Eikon: Further company coverage: